LenioBio GmbH

About LenioBio GmbH

LenioBio is dedicated to making life-saving medicines accessible to all through their innovative ALiCE(r) cell-free protein expression technology. Their mission is to simplify biomanufacturing and accelerate the delivery of drugs to patients by reinventing protein production.

Products & Services

ALiCE(r) for Research:A solution for small-scale protein expression, ideal for research purposes.

ALiCE(r) for Scale-Up:Designed for large-scale protein production to advance biomanufacturing.

ALiCE(r) for High-Throughput Expression (HTPE):Accelerates antibody screening with seamless integration, producing fully functional antibodies in 24 hours.

ALiCE(r) as a Service:An end-to-end solution for novel protein development, offering custom solutions for product roadmaps.

Specialties

Cell-free protein expression Eukaryotic protein production Scalable biomanufacturing Rapid protein synthesis for vaccines and therapeutics Membrane protein expression

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 3996000 MR: - FA: EUR 3.7M FAN: 3996000	D: 2025-07-23 FD: 2025-07-23	2 investors

Grant Latest

2025-07-23

$4.0M

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

R

Remberto Martis

Founder

M

Maja Lieven

Head of Protein Service

C

Charles Williams

Lead Strategic Projects

R

Ridhima Gomkale

Platform Development Scientist

J

Jorge Armero Gimenez

Platform Development Scientist

J

Johannes Gottschalk

Senior Protein Production Scientist

View 11 more team members with Pro

Unlock Full Team Directory

Recent News

LenioBio GmbH Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised